TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

ADAPTIS

NeurologyImmunologyOncology
Generics

ADAPTIS is a generic drug manufacturer focused on Neurology, Immunology, Oncology.

1986
Since
17
Drugs
-
Trials
354
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

PREGABALIN 2026-02-24
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-03
Labeling
PREGABALIN 2026-02-02
Labeling
PREGABALIN 2026-02-02
Labeling
VENLAFAXINE HYDROCHLORIDE 2026-01-30
Labeling
PREGABALIN 2025-12-29
Labeling
AMANTADINE HYDROCHLORIDE 2025-12-05
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 40%
2 drugs
Immunology 20%
1 drugs
Oncology 20%
1 drugs
Gastroenterology 20%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Bristol-Myers Squibb big-pharma
Oncology, Immunology, Gastroenterology, Neurology
Pfizer big-pharma
Oncology, Immunology, Gastroenterology
Takeda big-pharma
Immunology, Oncology, Gastroenterology, Neurology
AbbVie big-pharma
Immunology, Oncology, Neurology
Amgen biotech
Oncology, Immunology, Gastroenterology, Neurology